https://www.marketscreener.com/quote/stock/NAVIDEA-BIOPHARMACEUTICAL-58002405/news/Navidea-Biopharmaceuticals-Inc-Opens-Nine-New-Sites-in-Its-Pivotal-Phase-3-Trial-in-Rheumatoid-Art-41685171/?utm_source=telegram&utm_medium=social&utm_campaign=share